Investigational Site Number : 826003

Birmingham B9 5SS

0 studies enrolling now · 4 studies all time

What they study most

Fabry Disease, Glycogen Storage Disease Type II (GSD II), Hematopoietic Neoplasm, Multiple Sclerosis, Pompe Disease

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease — Completed
• Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease — Completed